Q4 2013
Released Mar 31, 2014, during market hours
10-K filed Mar 31, 2014, 90 days after period end · 0001144204-14-019291
Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$4.39M-$4.39M derivedN/M vs Q4 2012N/M vs Q3 2013
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$4,412,506—
Operating Cash Flowderived-$4,113,068—
Free Cash Flowderived-$4,113,068N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011 |
|---|---|---|---|
| Net Income | -$4.39M | $5.02M | -$5.16K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR